Im going long on Insy. I've been tracking and accumulating small positions over the last few months(with a purchase at 14.80 & out at 17 most recently. ) and I think this is going to break out of this current zone and enter into a new era leading up to the end of year DEA rescheduling. This will track around 25-30$ until then and we may see it revisit levels from 2015 (around $40-45) once we are reaffirmed with good ER & DEA news. Insys in my humble opinion is a strong buy. Things I would watch out for include manufacturing difficulties as well as supplier deficiencies with their new drug Syndros.
